Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corporation    EW

EDWARDS LIFESCIENCES CORPORATION (EW)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/09/2018 07/10/2018 07/11/2018 07/12/2018 07/13/2018 Date
146.99(c) 147.05(c) 144.65(c) 147.17(c) 148.13(c) Last
1 185 902 619 859 1 889 745 1 023 579 963 778 Volume
-0.37% +0.04% -1.63% +1.74% +0.65% Change
More quotes
Financials (USD)
Sales 2018 3 846 M
EBIT 2018 1 164 M
Net income 2018 943 M
Finance 2018 449 M
Yield 2018 -
Sales 2019 4 226 M
EBIT 2019 1 317 M
Net income 2019 1 079 M
Finance 2019 1 184 M
Yield 2019 -
P/E ratio 2018 32,83
P/E ratio 2019 28,77
EV / Sales2018 8,00x
EV / Sales2019 7,11x
Capitalization 31 223 M
More Financials
Company
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring.It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World.Its products are categorized into three areas: Surgical Heart... 
More about the company
Surperformance© ratings of Edwards Lifesciences Corpo
Trading Rating : Investor Rating :
More Ratings
Latest news on EDWARDS LIFESCIENCES CORPO
07/12EDWARDS LIFESCIENCES : Patent Issued for Prosthetic Valve for Replacing a Mitral..
AQ
07/12EDWARDS LIFESCIENCES : Researchers Submit Patent Application, "Inverted Leaflet ..
AQ
07/12EDWARDS LIFESCIENCES : Patent Issued for Low-Profile Prosthetic Heart Valve for ..
AQ
07/12EDWARDS LIFESCIENCES : Patent Issued for Integrated Heart Valve Delivery System ..
AQ
07/12EDWARDS LIFESCIENCES : Patent Issued for Conical Crimper (USPTO 10010412)
AQ
07/12EDWARDS LIFESCIENCES : To Host Earnings Conference Call on July 26, 2018
PR
07/05EDWARDS LIFESCIENCES : Patent Issued for Single Catheter Heart Repair Device and..
AQ
07/05EDWARDS LIFESCIENCES : Patent Issued for System and Method for Treating Valve In..
AQ
07/05EDWARDS LIFESCIENCES : Patent Issued for Devices, Systems and Methods for Accura..
AQ
06/30EDWARDS LIFESCIENCES : Comments on CMS Initiation of National Coverage Analysis ..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/12ROYAL PHILIPS : Philips Signs Long-Term Partnerships Worth EUR140 Million
DJ
07/11Brazil prosecutors allege jailed GE executive helped company partake in medic..
RE
07/06Correction to Tariffs Shock Waves Article on Thursday
DJ
07/06ROYAL PHILIPS : Philips to set aside $35 million for potential EU price-fixing f..
RE
07/05Even Before Tariffs Hit, Shock Waves Ripple Through World Economy -- 2nd Upda..
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on EDWARDS LIFESCIENCES CORPO 
EDWARDS LIFESCIENCES - 2016
Still a great upward potential
BUY
EDWARDS LIFESCIENCES  - 2015
Trading opportunity
BUY
More Strategies
Latest Tweets
07/15Edwards Lifesciences $EW Stock Rating Upgraded by Zacks Investment Research  
07/15Insider Selling: Edwards Lifesciences Corp $EW VP Sells 5,500 Shares of Stock.. 
07/15Edwards Lifesciences Corp $EW VP Donald E. Bobo, Jr. Sells 5,500 Shares of St.. 
07/12Edwards Lifesciences To Host Earnings Conference Call on July 26, 2018  
07/12Edwards Lifesciences $EW Price Target Raised to $162.00 at BMO Capital Market.. 
More tweets
Qtime:82
News from SeekingAlpha
07/06Med devices group joins broad rally 
06/13Headlines Don't Determine Stock Prices - Cramer's Mad Money (6/12/18) 
06/06Don't Let Go Of Hasbro - Cramer's Lightning Round (6/5/18) 
05/31Premarket analyst action - healthcare 
05/12EDWARDS LIFESCIENCES : Treating The #1 Killer In America 
Chart EDWARDS LIFESCIENCES CORPO
Duration : Period :
Edwards Lifesciences Corpo Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Technical analysis trends EDWARDS LIFESCIENCES CORPO
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 152 $
Spread / Average Target 2,4%
EPS Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John P. McGrath Vice President-Quality, Regulatory & Clinical
William J. Link Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORPORATION31.43%31 223
THERMO FISHER SCIENTIFIC11.23%84 971
DANAHER CORPORATION6.87%69 298
INTUITIVE SURGICAL43.68%59 405
BOSTON SCIENTIFIC CORPORATION34.53%46 017
ILLUMINA39.45%45 128